Sfoglia per RIVISTA
HAEMATOLOGICA
Collezione ASL Asti

  

Items : 13

OBINUTUZUMAB PLUS CHLORAMBUCIL VERSUS IBRUTINIB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 DISRUPTIONS. A CAMPUS CLL STUDY in Haematologica

2021
ASL Asti

Visentin A; Pravato S; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfò L; Guardalben E; Avitabile A; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Gattei V; Foà R; Massaia M; Gaidano G; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Magliulo D; Rossi D; Marchetti M; Bonello L; Pozzato G; Bo MD; Kopecka J; Bomben R; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V; Coscia M;

Droplet Digital PCR for Non-Invasive Mutational Screening in WaldenstrÃm Macroglobulinemia and IGM-MGUS: First Results of the Fondazione Italiana Linfomi (FIL) Bio-WM Trial in Haematologica

2020
ASL Asti
AOU Città della Salute di Torino

Cavallo F; Arcaini L; Boccadoro M; Garcia Sanz R; Varettoni M; Marcheselli L; Gilestro M; Picone C; Dogliotti I; Defrancesco I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Puig N; Rattotti S; Zibellini S; Candido C; Drandi D; Ferrero S; Ferrante M; et alii...

Complex Karyotype Is Associated with A Less Favorable Outcome after Ibrutinib and Rituximab As Front-Line Treatment of Unfit Patients with Chronic Lymphocytic Leukemia (GIMEMA LLC1114) in Haematologica

2020
ASL Asti

Del Giudice I; Rigolin GM; Bardi A; Melandri A; Cavallari M; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Fabri S; Albano F; Nanni M; Molica S; Reda G; Sportoletti M; Trentin L; Marchetti M; Peragine N; Mariglia P; Vignetti M; Mauro FR; Guarini A; Foà R; Cuneo A;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica

2020
ASL Asti

Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica

2020
ASL Asti

Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;

Efficacy and safety of front-line treatment with ibrutinib and rituximab in unfit patients with chronic lymphocytic leukemia (CLL). First report of the GIMEMA LLC1114 study in Haematologica

2019
ASL Asti
AO Ordine Mauriziano

Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati M; Gottardi D; Re F; Ilariucci F; Zinzani PL; Mannina D; Gozzetti A; Molinari AL; Gentile M; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Murru R; Tani M; et alii...

Clinical characteristics and outcome of west nile virus infection in patients with lymphoproliferative diseases: A multicenter study in Haematologica

2019
ASL Asti

Visentin A; Nasillo V; Marchetti M; Ferrarini I; Paolini R; Sancetta R; Rigolin GM; Cibien F; Imbergamo S; Riva M; Briani C; Marinello S; Piazza F; Gherlinzoni F; Krampera M; Bassan R; Cuneo A; Marasca R; Semenzato G; Trentin L;

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Eyre TA; Kennedy B; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Re F; Gaidano G; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Amendola A; Billio A; Visco C; Mauro FR; Galieni P; Orlandi EM; Farina L; Delgado AR; Musuraca G; Laurenti L; Coscia M; Perez AM; et alii...

Erythropoiesis stimulating agents can improve anemia in patients with myelofibrosis treated with ruxolitinib in Haematologica

2017
ASL Asti
AO Ordine Mauriziano

Crisà E; Daniela C; Elli EM; Beggiato E; Frairia C; Cerrano M; Lanzarone G; Marchetti M; Mezzabotta M; Boccadoro M; Ferrero D;

Cost-effectiveness of edoxaban, apixaban, rivaroxaban and dabigatran versus warfarin for stroke prevention in nonvalvular atrial fibrillation in Haematologica

2014
ASL Asti

Marchetti M; Liberato NL; Rognoni C; Quaglini S;

RWPSS validation in an independent cohort of 946 myelodysplastic syndrome patients from the MDS piedmont registry in Haematologica

2012
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo

Messa E; Gioia D; Salvi F; Allione B; Audisio E; Ferrero D; Crisà E; Lunghi M; Freilone R; Falco P; Cametti G; Bonferroni M; Ciravegna G; Cilloni D; Saglio G; Levis A;

Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome in Haematologica

2004
ASL Asti
ASL Cuneo 2

Ferrero D; Campa E; Dellacasa C; Campana S; Foli C; Boccadoro M;